Skip to main content
. 2018 Apr 6;19(3):215–226. doi: 10.1002/acm2.12322

Table 2.

Summary of plans used to validate the HN model including different combinations of dose prescriptions

Number of Targets Number of plans Dose (Gy) prescription's combinations
3 26 (70,63,56), (70,59,54), (70, 59, 50), (70,56,52), (66,59,56), (66,60,54)
2 16 (70,63), (70,60), (66,60), (66,56), (66,54), (60,54), (50,45)
1 19 70, 66, 60, 50, 36, 24